FDA Thwarts Leo Pharma's US Launch Plans For Tralokinumab

Agency Issues CRL For Atopic Dermatitis Drug

 
• By Kevin Grogan
Rhino
Tralokinumab path to approval blocked • Source: Alamy

More from Dermatological

More from Therapeutic Category